Skip to main content
    B

    Bone Biologics Corp (BBLG)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.29
    -0.00 (-0.75%)

    Market Cap: $1.10M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Bone Biologics Corp (BBLG) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bone Biologics (BBLG) has a market cap of $1.10M. Its share count is up 108.20% from a year earlier. It holds $6.09M more cash than debt, 552.56% of its market cap.

    Total Valuation

    Market Cap$1.10M
    Latest price (Nov 17, 2026)$0.29

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateOct 26, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 108.00% in the quarter ended Sep 30, 2026 and grew 257.62% a year over 2 years.

    Shares Outstanding3.74M
    Shares Change (YoY)+108.20%
    Shares Change (QoQ)+108.00%
    Share Count Growth (2Y CAGR)+257.62%

    Price Statistics

    The stock is down 81.75% over 52 weeks and trades 32.56% below its 50-day average.

    Beta (1Y)1.06
    52-Week Change-81.75%
    1-Month Change-28.87%
    3-Month Change-54.39%
    6-Month Change-76.83%
    5-Year Change-99.99%
    10-Year Change-99.99%
    Total Return (1Y)-81.75%
    Total Return (3Y CAGR)-78.47%
    Total Return (5Y CAGR)-85.80%
    Max Drawdown (1Y)-86.16%
    Max Drawdown (3Y)-99.19%
    Sharpe Ratio (1Y)-2.40
    Correlation with SPY (1Y)0.20
    50-Day Average$0.43
    200-Day Average$0.98
    52-Week Range$0.27 to $2.39
    RSI (14 Days)32.1
    Average Volume (20 Days)458.64K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 13.38x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio13.38x
    Quick Ratio13.38x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -47.75% and return on assets is -44.18% over the last 12 months.

    Return on Equity (ROE)-47.75%
    Return on Assets (ROA)-44.18%
    ROA (5Y Average)-88.23%
    ROIC (5Y Average)-92.40%

    Scores

    BBLG has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$3.01M
    Pretax Income-$2.84M
    Net Income-$2.84M
    Reported EPS (TTM)-$1.66

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 92.53% of the $6.43M in total assets.

    Cash and Equivalents$6.09M
    Total Debt$0
    Net Cash$6.09M
    Net Cash Per Share$1.63
    Working Capital$5.95M
    Shareholder Equity$5.95M
    Book Value Per Share$1.59
    Total Assets$6.43M
    Total Liabilities$480.77K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $5 of capital spending, operating cash flow left -$2.57M of free cash flow.

    Operating Cash Flow-$2.57M
    Capital Expenditures$5
    Free Cash Flow-$2.57M
    FCF Per Share-$0.76

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-65.29%
    Tangible Book Per Share Growth (2Y CAGR)-65.29%

    Revenue and profit by year

    Stock Splits

    The last split was a 1-for-6 reverse split on Jun 10, 2025.

    Last Split DateJun 10, 2025
    Split TypeReverse split
    Split Ratio1:6

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BBLG

    What is BBLG's market cap?

    Bone Biologics has a market cap of $1.10M.

    How many shares of BBLG are outstanding?

    Bone Biologics has 3.74M shares outstanding. The count is up 108.20% from a year earlier.

    Does BBLG pay a dividend?

    No. Bone Biologics does not pay a dividend.

    How much debt does BBLG have?

    Bone Biologics has $0 of total debt and $6.09M of cash and equivalents, a net cash position of $6.09M.